Home › Medulloblastoma › Connecticut › Hartford
Medulloblastoma clinical trials in Hartford, CT
3 studies for Medulloblastoma are looking for participants at sites in and around Hartford (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Digoxin Medulloblastoma Study
RecruitingPhase 2
- Connecticut Children's Medical Center, Hartford
A Study of Treatment for Medulloblastoma Using Sodium Thiosulfate to Reduce Hearing Loss
RecruitingPhase 3
- Connecticut Children's Medical Center, Hartford
DFMO as Maintenance Therapy for Molecular High/Very High Risk and Relapsed Medulloblastoma
RecruitingPhase 2
- Connecticut Children's Hospital, Hartford
Medulloblastoma trials in other cities
- Washington, DC9 studies
- St. Louis, MO6 studies
- Houston, TX4 studies
- New York City, NY4 studies
- Durham, NC4 studies
- Philadelphia, PA4 studies
- Seattle, WA4 studies
- Miami, FL4 studies
- Tampa, FL4 studies
- Memphis, TN3 studies
- Boston, MA3 studies
- Ann Arbor, MI3 studies
Other studies in Hartford
- Non-Small Cell Lung Cancer12 studies
- Lung Cancer11 studies
- Major Depressive Disorder9 studies
- Cancer (all types)9 studies
- Breast Cancer9 studies
- Neuroblastoma8 studies
- Multiple Myeloma7 studies
- Pancreatic Cancer7 studies
- Prostate Cancer7 studies
- Ovarian Cancer7 studies
- Cardiovascular Disease7 studies
- Heart Failure7 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.